Structures by: Tier A. Z.
Total: 19
Salicylic acid/1,2-Phenylendiamine
C7H5O3,C6H9N2
CrystEngComm (2020) 22, 4 708-719
a=4.7829(14)Å b=11.669(4)Å c=21.830(7)Å
α=90° β=93.778(12)° γ=90°
Pyrazolo[1,5-a]pyrimidine
C14H9BrF3N3
CrystEngComm (2015) 17, 23 4325
a=4.7574(7)Å b=11.0476(17)Å c=26.177(5)Å
α=90° β=90° γ=90°
Pyrazolo[1,5-a]pyrimidine
C13H10FN3
CrystEngComm (2015) 17, 23 4325
a=3.8161(2)Å b=10.6532(5)Å c=25.8317(12)Å
α=90° β=90.724(3)° γ=90°
Pyrazolo[1,5-a]pyrimidine
C13H11N3
CrystEngComm (2015) 17, 23 4325
a=3.9185(3)Å b=10.5324(10)Å c=25.539(2)Å
α=90° β=90.642(3)° γ=90°
Pyrazolo[1,5-a]pyrimidine
C13H10BrN3
CrystEngComm (2015) 17, 23 4325
a=3.91340(10)Å b=10.8096(2)Å c=13.8568(3)Å
α=90° β=96.9070(10)° γ=90°
Pyrazolo[1,5-a]pyrimidine
C12H10N4
CrystEngComm (2015) 17, 23 4325
a=4.0774(3)Å b=12.7591(6)Å c=19.5223(9)Å
α=90° β=90° γ=90°
Pyrazolo[1,5-a]pyrimidine
C9H8Cl3N3
CrystEngComm (2015) 17, 23 4325
a=10.3016(7)Å b=16.0564(11)Å c=6.8555(6)Å
α=90° β=93.098(5)° γ=90°
2-methyl-5-(naphthalen-2-yl)-7-(trifluorometh
C18H12F3N3
CrystEngComm (2015) 17, 23 4325
a=7.8462(5)Å b=11.2089(9)Å c=16.8641(12)Å
α=90° β=92.389(5)° γ=90°
Pyrazolo[1,5-a]pyrimidine
C8H5BrCl3N3
CrystEngComm (2015) 17, 23 4325
a=7.4329(2)Å b=6.7756(2)Å c=11.1667(3)Å
α=90° β=90.2760(10)° γ=90°
Pyrazolo[1,5-a]pyrimidine
C11H12Cl3N3
CrystEngComm (2015) 17, 23 4325
a=11.2451(8)Å b=5.8697(4)Å c=20.9201(16)Å
α=90° β=104.896(5)° γ=90°
Pyrazolo[1,5-a]pyrimidine
C9H7BrCl3N3
CrystEngComm (2015) 17, 23 4325
a=9.6363(3)Å b=6.9353(2)Å c=9.8541(3)Å
α=90° β=111.240(2)° γ=90°
Pyrazolo[1,5-a]pyrimidine
C15H12F3N3
CrystEngComm (2015) 17, 23 4325
a=4.8715(2)Å b=11.2655(5)Å c=13.5584(6)Å
α=110.225(3)° β=96.808(3)° γ=99.835(3)°
Chlorophenyl trifluoromethyl methylpyrirazole pyridine
C14H9ClF3N3
CrystEngComm (2015) 17, 23 4325
a=4.7929(4)Å b=10.5914(9)Å c=26.224(2)Å
α=90° β=90° γ=90°
C28H18N6
C28H18N6
CrystEngComm (2016) 18, 21 3866
a=31.5821(12)Å b=31.5821(12)Å c=5.8362(5)Å
α=90.00° β=90.00° γ=120.00°
C28H18N6
C28H18N6
CrystEngComm (2016) 18, 21 3866
a=11.8253(14)Å b=6.2971(5)Å c=15.069(2)Å
α=90.00° β=100.900(5)° γ=90.00°
4-iodo-5-methylisoxazol-3-amine
C4H5IN2O
CrystEngComm (2015) 17, 38 7381
a=6.5261(3)Å b=7.3488(3)Å c=7.6401(3)Å
α=96.998(3)° β=100.396(3)° γ=113.411(3)°
4-chloro-5-methylisoxazol-3-amine
C4H5ClN2O
CrystEngComm (2015) 17, 38 7381
a=6.9082(3)Å b=12.2055(7)Å c=14.2820(8)Å
α=90° β=90° γ=90°
4-bromo-5-methylisoxazol-3-amine
C4H5BrN2O
CrystEngComm (2015) 17, 38 7381
a=6.4176(7)Å b=7.1023(9)Å c=7.5370(10)Å
α=94.502(8)° β=100.535(7)° γ=115.558(6)°
1,8-bis(3-methylimidazolium-1-yl)
C16H28B2F8N4
CrystEngComm (2015) 17, 15 2996
a=5.4081(2)Å b=15.5202(8)Å c=13.3407(6)Å
α=90° β=100.649(2)° γ=90°